Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs
TM), today announced that it has entered into definitive agreements with several healthcare-focused institutional and other institutional investors for the sale of an aggregate of 40,000,000 shares of its common stock at a purchase price of $2.50 per share in a registered direct offering priced at-the-market under Nasdaq Rules. The offering is expected to close on or about February 8, 2021, subject to the satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The gross proceeds of the offering are expected to be $100 million, prior to deducting placement agent’s fees and other offering expenses payable by TYME. TYME intends to use the net proceeds from the offering for the development of the company’s clinical and preclinical assets and for general corporate purposes, capital expe
(TYME) - Why Tyme Technologies Shares Are Surging Higher benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Sino-Global Shipping America, Ltd. (NASDAQ: SINO) shares shot up 63% to $7.71
after the company announced a newly-appointed Chief Operating Officer and Chief Technology Officer to spearhead its efforts to enter Bitcoin mining.
Shares of GW Pharmaceuticals plc (NASDAQ: GWPH) got a boost, shooting 46% to $212.80 after the company announced it will be acquired by Jazz Pharmaceuticals for $7.2 billion.
Tyme Technologies Inc (NASDAQ: TYME) shares were also up, gaining 105% to $3.74 after the company was granted US patent claims covering the use of TYME-19 to treat COVID-19 infections.
Equities Trading DOWN
Vaxart, Inc. (NASDAQ: VXRT) shares tumbled 59% to $9.65 after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults.
Sino-Global Shipping America, Ltd. (NASDAQ: SINO) shares shot up 60% to $7.57
after the company announced a newly-appointed Chief Operating Officer and Chief Technology Officer to spearhead its efforts to enter Bitcoin mining.
Shares of GW Pharmaceuticals plc (NASDAQ: GWPH) got a boost, shooting 46% to $214.00 after the company announced it will be acquired by Jazz Pharmaceuticals for $7.2 billion.
Tyme Technologies Inc (NASDAQ: TYME) shares were also up, gaining 86% to $3.38 after the company was granted US patent claims covering the use of TYME-19 to treat COVID-19 infections.
Equities Trading DOWN
Vaxart, Inc. (NASDAQ: VXRT) shares tumbled 52% to $11.19 after reporting that neutralizing antibodies were not detected in volunteers after a single dose of its experimental oral COVID-19 vaccine candidate, VXA-CoV2-1, in a Phase 1 trial of 35 healthy adults.
;
Mid-afternoon market update: Dow gains 75 points; GW Pharmaceuticals (GWPH Stock) shares jump on acquisition newsNEWS |
2/3/2021 8:14:08 PM GMT | By Benzinga Team
Toward the end of trading Wednesday, the Dow traded up 0.25% to 30,763 while the NASDAQ rose 0.5% to 13,680.71. The S&P also rose, gaining 0.45% to 3,843.70.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 26,436,590 cases with around 446,900 deaths. India confirmed a total of at least 10,777,280 confirmed cases and 154,590 deaths, while Brazil reported over 9,283,410 COVID-19 cases with 226,300 deaths. In total, there were at least 103,972,190 cases of COVID-19 worldwide with over 2,255,490 deaths, according to data compiled by Johns Hopkins University.